EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reverse vaccinology-based identification of a novel surface lipoprotein that is an effective vaccine antigen against bovine infections caused by Pasteurella multocida

Epshita A Islam, Jamie E Fegan, Takele A Tefera, David M Curran, Regula C Waeckerlin, Dixon Ng, Sang Kyun Ahn, Chun Heng Royce Lai, Quynh Huong Nguyen, Megha Shah, Liyuwork Tesfaw, Kassaye Adamu und 10 weitere

PLOS Pathogens · 2023

DOI: 10.1371/journal.ppat.1011249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Epshita A Islam und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Pasteurella multocida, Hemorrhagic Septicemia, Pasteurella Infections. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, IDRC-LVIF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pasteurella multocida can infect a multitude of wild and domesticated animals, with infections in cattle resulting in hemorrhagic septicemia (HS) or contributing to bovine respiratory disease (BRD) complex. Current cattle vaccines against P . multocida consist of inactivated bacteria, which only offer limited and serogroup specific protection. Here, we describe a newly identified surface lipoprotein, PmSLP, that is present in nearly all annotated P . multocida strains isolated from cattle. Bovine associated variants span three of the four identified phylogenetic clusters, with PmSLP-1 and PmSLP-2 being restricted to BRD associated isolates and PmSLP-3 being restricted to isolates associated with HS. Recombinantly expressed, soluble PmSLP-1 (BRD-PmSLP) and PmSLP-3 (HS-PmSLP) vaccines were both able to provide full protection in a mouse sepsis model against the matched P . multocida strain, however no cross-protection and minimal serum IgG cross-reactivity was identified. Full protection against both challenge strains was achieved with a bivalent vaccine containing both BRD-PmSLP and HS-PmSLP, with serum IgG from immunized mice being highly reactive to both variants. Year-long stability studies with lyophilized antigen stored under various temperatures show no appreciable difference in biophysical properties or loss of efficacy in the mouse challenge model. PmSLP-1 and PmSLP-3 vaccines were each evaluated for immunogenicity in two independent cattle trials involving animals of different age ranges and breeds. In all four trials, vaccination with PmSLP resulted in an increase in antigen specific serum IgG over baseline. In a blinded cattle challenge study with a recently isolated HS strain, the matched HS-PmSLP vaccine showed strong efficacy (75–87.5% survival compared to 0% in the control group). Together, these data suggest that cattle vaccines composed of PmSLP antigens can be a practical and effective solution for preventing HS and BRD related P . multocida infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pasteurella multocidaHemorrhagic SepticemiaPasteurella InfectionsCattleAnimalsMicePhylogenyVaccinologyBacterial VaccinesDisease Models, AnimalImmunoglobulin G

Substanzen

Bacterial VaccinesImmunoglobulin G

Autor:innen und Institutionen

  • Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Department of Veterinary Bacteriology, National Veterinary Institute, Bishoftu, Ethiopia.
  • Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
  • Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
  • Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

ORCID-Profile: Scott D Gray-Owen, Trevor F Moraes

Förderung

  • CIHR
  • IDRC-LVIF

Zitieren

APA

Islam, E. A., Fegan, J. E., Tefera, T. A., Curran, D. M., Waeckerlin, R. C., Ng, D., Ahn, S. K., Lai, C. H. R., Nguyen, Q. H., Shah, M., Tesfaw, L., Adamu, K., Medhin, W. W., Legesse, A., Deresse, G., Getachew, B., Rawlyk, N., Evans, B., Potter, A., …, & Moraes, T. F. (2023). Reverse vaccinology-based identification of a novel surface lipoprotein that is an effective vaccine antigen against bovine infections caused by Pasteurella multocida. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011249

Vancouver

Islam EA, Fegan JE, Tefera TA, Curran DM, Waeckerlin RC, Ng D, et al. Reverse vaccinology-based identification of a novel surface lipoprotein that is an effective vaccine antigen against bovine infections caused by Pasteurella multocida. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011249

BibTeX
@article{Islam2023,
  author = {Islam, Epshita A and Fegan, Jamie E and Tefera, Takele A and Curran, David M and Waeckerlin, Regula C and Ng, Dixon and Ahn, Sang Kyun and Lai, Chun Heng Royce and Nguyen, Quynh Huong and Shah, Megha and Tesfaw, Liyuwork and Adamu, Kassaye and Medhin, Wubet W and Legesse, Abinet and Deresse, Getaw and Getachew, Belayneh and Rawlyk, Neil and Evans, Brock and Potter, Andrew and Schryvers, Anthony B and Gray-Owen, Scott D and Moraes, Trevor F},
  title = {Reverse vaccinology-based identification of a novel surface lipoprotein that is an effective vaccine antigen against bovine infections caused by Pasteurella multocida},
  journal = {PLOS Pathogens},
  year = {2023},
  doi = {10.1371/journal.ppat.1011249}
}
Kostenlos starten →